Crossmark

Accelerated hypofractionated radiotherapy plus chemotherapy for inoperable locally advanced non-small-cell lung cancer: final results of a prospective phase-II trial with a long-term follow-up

Crossref DOI link: https://doi.org/10.1186/s13014-019-1317-x

Published Online: 2019-06-24

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Parisi, Elisabetta

Genestreti, Giovenzio

Sarnelli, Anna

Ghigi, Giulia

Arpa, Donatella

Burgio, Marco Angelo

Gavelli, Giampaolo

Rossi, Alice

Scarpi, Emanuela

Monti, Manuela

Tesei, Anna

Polico, Rolando

Romeo, Antonino
License Information

Text and Data Mining valid from 2019-06-24

Version of Record valid from 2019-06-24
More Information

Article History

Received: 24 December 2018

Accepted: 6 June 2019

First Online: 24 June 2019

Ethics approval and consent to participate

: This study was approved by IRST IRCCS AVR Ethics Committee (approval no. 331 of 05/11/2008) and was conducted in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki. All patients gave written informed consent.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below